Cargando…
Systematic review reveals lack of quality in reporting health-related quality of life in patients with gastroenteropancreatic neuroendocrine tumours
BACKGROUND: Gastroenteropancreatic neuroendocrine tumours (GEP-NET) are often slow-growing and patients may live for years with metastasised disease. Hence, along with increasing overall and progression-free survival, treatments aim at preserving patients’ well-being and health-related quality of li...
Autores principales: | Martini, Caroline, Gamper, Eva-Maria, Wintner, Lisa, Nilica, Bernhard, Sperner-Unterweger, Barbara, Holzner, Bernhard, Virgolini, Irene |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5018190/ https://www.ncbi.nlm.nih.gov/pubmed/27614762 http://dx.doi.org/10.1186/s12955-016-0527-2 |
Ejemplares similares
-
Persistent quality of life impairments in differentiated thyroid cancer patients: results from a monitoring programme
por: Gamper, Eva-Maria, et al.
Publicado: (2015) -
Long-Term Survival and Value of (18)F-FDG PET/CT in Patients with Gastroenteropancreatic Neuroendocrine Tumors Treated with Second Peptide Receptor Radionuclide Therapy Course with (177)Lu-DOTATATE
por: Rodrigues, Margarida, et al.
Publicado: (2021) -
Self-reported sexual health: Breast cancer survivors compared to women from the general population – an observational study
por: Oberguggenberger, Anne, et al.
Publicado: (2017) -
Quality of life across chemotherapy lines in patients with cancers of the pancreas and biliary tract
por: Zabernigg, August, et al.
Publicado: (2012) -
Assessing quality of life on the day of chemotherapy administration underestimates patients’ true symptom burden
por: Giesinger, Johannes M, et al.
Publicado: (2014)